Nomenclature |
Peptide transporter 1 |
Peptide transporter 2 |
Peptide transporter 3 |
Peptide transporter 4 |
Systematic nomenclature |
SLC15A1 |
SLC15A2 |
SLC15A3 |
SLC15A4 |
Common abbreviation |
PepT1 |
PepT2 |
PHT2 |
PHT1 |
HGNC, UniProt |
SLC15A1, P46059
|
SLC15A2, Q16348
|
SLC15A3, Q8IY34
|
SLC15A4, Q8N697
|
Endogenous substrates |
5-aminolevulinic acid 253, dipeptides 253, tripeptides 253
|
5-aminolevulinic acid, dipeptides, tripeptides |
L-histidine, carnosine, dipeptides, tripeptides |
L-histidine, carnosine, dipeptides, tripeptides |
Substrates |
fMet-Leu-Phe 260, cyclacillin 254, valacyclovir 255, cefadroxil 254, muramyl dipeptide 268
|
cyclacillin 254, cefadroxil 254
|
– |
valacyclovir 247
|
Inhibitors (pIC50) |
4-AMBA 252, Lys[Z(NO2)]-Pro 258
|
Lys[Z(NO2)]-Lys[Z(NO2)] 248,267, Lys[Z(NO2)]-Pro |
– |
– |
Radioligands (Kd) |
[11C]GlySar, [14C]GlySar, [3H]GlySar |
[11C]GlySar, [14C]GlySar, [3H]GlySar |
[14C]histidine, [3H]histidine |
[14C]histidine, [3H]histidine |
Stoichiometry |
1 H+: 1 zwitterionic peptide (in) |
2 H+: 1 zwitterionic peptide (in) |
Unknown |
Unknown |